David Krige Email & Phone Number
Chief Development Officer (CDO) @ Accession Therapeutics Limited
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
David Krige Location
- Oxford, GB
David Krige Work
- Chief Development Officer (CDO) @ (September 2025 - Present)
- Head of Translational Sciences @ (October 2022 - September 2025)
- Vice President, Translational Medicine @ (September 2019 - October 2022)
- Director of Translational Medicine @ (May 2018 - September 2019)
- Head of Biomarkers @ (June 2014 - May 2018)
- Head of Drug Discovery, Science Funding Dept @ (October 2012 - June 2014)
- Group and Project Leader, Biology @ Chroma Therapeutics (January 2004 - January 2012)
- Team Leader, Gene Discovery @ (January 2000 - January 2003)
- Senior Scientist @ British Biotech (January 1994 - January 2000)
- PhD @ Royal Free Hospital, University of London (January 1990 - January 1994)
David Krige Education
- Royal Free Hospital, University of London
PhD (Biochemistry)
1990-1994 - UCL
MSc (Applied Molecular Biology and Biotechnology; distinction)
1988-1989 - Queen Mary University of London
BSc (Genetics)
1985-1988
David Krige Skills
- Molecular Biology
- Biochemistry
- Genomics
- Cell Based Assays
- Drug Discovery
- Oncology
- Cell Biology
- Customer Service
- Biomarkers
- Research
- Data Analysis
David Krige Summary
- David Krige, based in Oxford, GB, is currently a Chief Development Officer (CDO) at Accession Therapeutics Limited. David Krige brings experience from previous roles at Accession Therapeutics Limited, PsiOxus Therapeutics Ltd and Immunocore. David Krige holds a 1990 - 1994 PhD in Biochemistry @ Royal Free Hospital, University of London. With a robust skill set that includes Molecular Biology, Biochemistry, Genomics, Cell Based Assays, Drug Discovery and more. David Krige has 1 emails on RocketReach.
Looking for a different David Krige?
Find contact details for 700 million professionals.
Others Named David Krige
David Krige
Chief Development Officer (CDO)
Oxford, GB
David Krige
Financial Controller
Whangarei, NZ
David Krige
Propulsion Engineer
South Africa
Top Accession Therapeutics Limited Employees
Bent Jakobsen
Founder and CEO
Oxford, GB
David Krige
Chief Development Officer (CDO)
Oxford, GB
Andy Johnson
Head of CMC
Oxford, GB
Stephanie Bewick
Chief Business Officer
Oxford, GB
Chris Cox
Director, Translational Sciences
Wantage, GB
Rita Figueiredo
Director Research Strategy
Oxford, GB
Ryea Maswood
Principal Scientist - CMC
Oxford, GB
Emily Trimby
Senior Scientist
Horspath, GB
Thomas Webb
Senior Scientist
Cardiff, GB
Sarah Kernaghan
Clinical Study Manager
London, England, GB
Nick Cross
Chairman of the Board
Dry Sandford, GB
Tania Selas
Principal Scientist
Oxford, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co